Top M3541 Secrets
The first stop stage was the protection and tolerability of sifalimumab. Treatment-emergent adverse events (AEs) and critical AEs (SAEs) as well as their severity, outcome, and any romantic relationship on the analyze medication had been recorded because of the investigator through the study. AEs had been viewed as very likely to be relevant to ana